Allergy Diagnostics and Therapeutics Market Set for Significant Growth, Expected to Reach $55 Billion by 2030
According to Next Move Strategy Consulting, the global Allergy Diagnostics and Therapeutics Market is projected to grow $55 billion by 2030, achieving a compound annual growth rate (CAGR) of 6% from 2023 to 2030, according to a new market research report. This growth is driven by rising incidences of allergic reactions and increased demand for accurate diagnostics and effective treatments.
The allergy diagnostics and therapeutics market encompasses a broad spectrum of products and services aimed at diagnosing and treating allergic diseases, which range from mild to severe reactions triggered by allergens such as food, pollen, dust, and medications. With increasing awareness around allergies, these products and services help healthcare professionals identify allergens, improve patient outcomes, and reduce the severity and frequency of allergic reactions.
Download Free Sample: https://www.nextmsc.com/allergy-diagnostics-and-therapeutics-market/request-sample
Market Dynamics and Trends
A key factor driving the market is the growing concern over skin allergies caused by rising global temperatures and air pollution, which have been linked to a higher incidence of skin cancer. According to a 2020 report from the World Health Organization (WHO), melanoma cases have surged globally, with over 325,000 new diagnoses and 57,000 deaths reported. Additionally, the growing focus on advanced automation devices, such as the RIDA qLine autoBlot, which automates allergy membrane detection, is expected to further boost the market.
The market is also benefiting from the increasing adoption of in-vitro diagnostic tests and the expansion of medical insurance policies designed to offer greater access to allergy care. For instance, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), introduced measures to help consumers identify appropriate, affordable healthcare coverage on HealthCare.gov, which directly impacts the allergy diagnostics landscape.
However, challenges such as stringent regulatory requirements and the lack of standardized protocols for allergy diagnosis and treatment may restrain market growth. Despite these obstacles, the ongoing trend toward personalized medicine presents a significant opportunity for companies that can develop targeted allergy diagnostics and therapies.
Inquire Before Buying: https://www.nextmsc.com/allergy-diagnostics-and-therapeutics-market/inquire-before-buying
Market Segmentation
The allergy diagnostics and therapeutics market is segmented based on type, product, test, allergen, drug class, end user, and region:
- Type: Fungal Allergy Diagnostics, Neutral Lactase Enzymes
- Product: Instruments (Immunoassay Analyzers, Elisa Analyzers, Luminometers), Consumables, Services
- Test: Vivo Tests (Skin Prick Tests, Patch Tests) and Vitro Tests
- Allergen: Inhaled Allergens, Food Allergens, Drug Allergens
- Drug Class: E-Congestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, and more
- End User: Hospitals, Diagnostic Laboratories, Academic Research Institutions
- Regions: North America, Europe, Asia-Pacific, and the Rest of the World
Geographical Insights
North America is poised to maintain its dominant position in the market due to the region's increasing adoption of personalized medicine and advancements in diagnostic technologies. Strategic partnerships, like the collaboration between Thermo Fisher Scientific and Mayo Clinic, are accelerating clinical validation and commercialization of next-generation diagnostic tools in the region.
Meanwhile, the Asia-Pacific region, home to a vast population and increasing pollution levels, is expected to see substantial market growth. The rise in allergy cases, particularly in countries like China and India, presents significant opportunities for companies specializing in allergy diagnostics and therapeutics.
Competitive Landscape
The allergy diagnostics and therapeutics market is highly competitive, with key players including:
- Thermo Fisher Scientific Inc.
- Danaher Corp.
- Siemens Healthcare Diagnostics, Inc.
- Biomérieux SA
- Hitachi Chemical Diagnostic Inc.
- Lincoln Diagnostics Inc.
- Eurofins Scientific
- Stallergenes SA
- Omega Diagnostics LLC
- Minaris Medical America
These companies are adopting strategies such as innovation, partnerships, and mergers and acquisitions to maintain their leadership. For example, Thermo Fisher Scientific received FDA clearance in August 2022 for its ImmunoCAP Specific IgE Allergen Components for wheat and sesame allergies. Eurofins Scientific also introduced new ELISA tests in 2021, enhancing allergen analysis, particularly for processed foods.
Conclusion
The global allergy diagnostics and therapeutics market is on an upward trajectory, driven by increasing allergy incidences, technological advancements, and a rising focus on personalized medicine. With strong growth expected in North America and Asia-Pacific, companies that invest in innovation and expand their offerings are well-positioned to capitalize on this expanding market. However, stakeholders must also navigate regulatory hurdles and address inconsistencies in diagnostic standards to fully realize the market's potential.
Also, Browse Related Reports:
For more information, please contact:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.